Financial Daily from THE HINDU group of publications
Saturday, Jul 13, 2002

News
Features
Stocks
Port Info
Archives

Group Sites

Corporate - Announcements
Variety - Health


Lasik facility at CDR hospital

Our Bureau

HYDERABAD, July 12

CDR, the Hyderabad-based corporate hospital, has introduced the laser eyesight correction facility called Lasik, which uses ultraviolet radiation.

The Rs 2 crore-equipment has been imported from Schwind of Germany through Wipro Biomed, the India distributor, according to Dr C. Dayakar Reddy, Chairman of CDR.

Lasik laser eye surgery is an established method in most developed nations. The facility as well as the expertise are available at leading hospitals in the country. Basic eyesight problems can be corrected with best results for people in the 20-40 year group, said Dr T. Balchender, ophthalmologist at CDR.

The difference that CDR claims to make is in bringing this facility at comparatively low costs. "We will do the surgery in both eyes for Rs 24,000, while the cost is around Rs 40,000 elsewhere," Dr Dayakar Reddy said.

The Lasik (laser in-situ keratomileusis) procedure offers the advantage of correcting errors not just associated with the cornea of the eye but the entire optic track, thereby providing better vision to the patient, Dr Balchender told presspersons on Friday.

In this method the eye surgeon creates and lifts a thin layer of tissue from the front surface of the cornea and uses excimer laser to gently sculpt the corneal tissue to correct the vision. Once this is done, the tissue is replaced. The entire operation would take about 30 minutes, he said.

Send this article to Friends by E-Mail

Stories in this Section
German lender backs RSP periphery development


Lasik facility at CDR hospital
Holiday Inn office
HLL board meet on July 22
Levi Strauss' raid on fakes
CESC told to revise tariff only with SC approval
Dunlop allowed to remove papers
Coromandel Fert closes down ammonia unit — Writes off Rs 25 cr
Escorts to get Rs 235 cr from divesting in 3 cos
Ispat defers decision on package
HC takes up Jessop case hearing
Neuland Labs to cash in on USFDA approvals
SET hopes to make profits this year
IOC only Indian Fortune 500 co


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright © 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line